PT Kalbe Farma Tbk. (KLBF.JK)

1,400.00 -15.00 (-1.06%) At close: 04:14PM WIB

PT Kalbe Farma Tbk.

Gedung KALBE
Jl. Let. Jend. Suprapto Kav. 4 Cempaka Putih
Jakarta 10510
Indonesia
62 21 4287 3888
https://www.kalbe.co.id

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 13,108

Key executives

Name	Title	Pay	Exercised	Year born
Mr. . Vidjongtius	President Director	N/A	N/A	1964
Ms. Lanny Soputro	Director of Human Resources, General Affairs & HSSE	N/A	N/A	1964
Mr. Kurniawan Suhartono	Head of Internal Audit Unit	N/A	N/A	1965
Mr. Sie Djohan	Director of Corporate Business Development, Management System & Regulatory Affairs and Director	N/A	N/A	1967
Maria Teresa Fabiola	Corporate Secretary	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.

Description

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals and Distribution; and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Corporate governance

PT Kalbe Farma Tbk.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.